A possible case of natalizumab-dependent suicide attempt: A brief review about drugs and suicide

β-Interferon therapy is known to be a potential trigger of suicidal behavior, but this effect has not been previously reported for other multiple sclerosis (MS) treatments, such as, natalizumab. Here we report the case history of a 32-year-old woman affected by relapsing-remitting MS, who attempted...

Descripción completa

Detalles Bibliográficos
Autores principales: Mumoli, Laura, Ciriaco, Miriam, Gambardella, Antonio, Bombardiere, Giuseppe Nicodemo, Valentino, Paola, Palleria, Caterina, Labate, Angelo, Russo, Emilio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2013
Materias:
Case Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853678/
https://www.ncbi.nlm.nih.gov/pubmed/24347991
http://dx.doi.org/10.4103/0976-500X.120974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3853678/
https://www.ncbi.nlm.nih.gov/pubmed/24347991
http://dx.doi.org/10.4103/0976-500X.120974

Ejemplares similares